Since 2009, we have been able to offer therapeutic regimes with lenalidomide (Revlimid) also to our patients in the Czech Republic, Slovak Republic and Slovenia. I am very glad that the workshop of Celgene company was dedicated exactly to this drug.
01. 04. 2010